A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study

Author:

Pan Sung-Ching,Hsu Wei-Ting,Lee Wen-Sen,Wang Ning-Chi,Chen Tzeng-Ji,Liu Ming-Che,Pai Hui-Chen,Hsu Yu-Shen,Chang Mingi,Hsieh Szu-Min

Funder

Ministry of Economic Affairs, ROC

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. World Health Organization. A Manual for Estimating Disease Burden Associated With Seasonal Influenza. WHO; 2015. Accessed on July 4, 2019. http://apps.who.int/iris/bitstream/handle/10665/178801/9789241549301_eng.pdf;jsessionid=C8A652DA5C3D72F43EE7F004CA992EFE?sequence=1.

2. Seasonal influenza vaccination coverage among adult populations in the United States, 2005–2011;Lu;Am J Epidemiol,2013

3. WHO. Newsroom Influenza (seasonal). 2018. Accessed July 4, 2019. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal).

4. Intranasal administration of whole inactivated influenza virus vaccine as a promising influenza vaccine candidate;Ainai;Viral Immunol,2017

5. Intranasal inactivated influenza vaccines: a reasonable approach to improve the efficacy of influenza vaccine?;Tamura;Japanese J Infect Dis,2016

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Induction of protective immune responses at respiratory mucosal sites;Human Vaccines & Immunotherapeutics;2024-07-02

2. Recent advances in enterotoxin vaccine adjuvants;Current Opinion in Immunology;2023-12

3. Recent advances in respiratory immunization: A focus on COVID-19 vaccines;Journal of Controlled Release;2023-03

4. Surveys in Health Services Research in Pharmacy;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023

5. Surveys in Health Services Research in Pharmacy;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3